Apellis Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q1 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of unrecognized tax benefits.
Summary: Apellis Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q1 2021 to Q3 2024.
Apellis Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending September 30, 2024 was $0.000.

Unrecognized Tax Benefits, Quarterly (USD)

Unrecognized Tax Benefits, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$0	$0		Sep 30, 2024	10-Q	2024-11-05
Q2 2024	$0	$0		Jun 30, 2024	10-Q	2024-08-01
Q1 2024	$0			Mar 31, 2024	10-Q	2024-05-07
Q4 2023	$0			Dec 31, 2023	10-Q	2024-11-05
Q3 2023	$0	-$1.9M	-100%	Sep 30, 2023	10-Q	2023-11-01
Q2 2023	$0	-$1.6M	-100%	Jun 30, 2023	10-Q	2023-07-31
Q3 2022	$1.9M	+$1.9M		Sep 30, 2022	10-Q	2022-11-07
Q2 2022	$1.6M	+$1.6M		Jun 30, 2022	10-Q	2022-08-08
Q1 2022	$1.2M	+$1.2M		Mar 31, 2022	10-Q	2022-05-04
Q3 2021	$0			Sep 30, 2021	10-Q	2021-11-08
Q2 2021	$0			Jun 30, 2021	10-Q	2021-08-09
Q1 2021	$0			Mar 31, 2021	10-Q	2021-04-28

Showing 1 to 12 of 12 entries

* An asterisk sign (*) next to the value indicates that the value is likely invalid.